Your browser doesn't support javascript.
loading
Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile.
Donaghy, Paul C; Ciafone, Joanna; Durcan, Rory; Hamilton, Calum A; Barker, Sally; Lloyd, Jim; Firbank, Michael; Allan, Louise M; O'Brien, John T; Taylor, John-Paul; Thomas, Alan J.
Affiliation
  • Donaghy PC; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Ciafone J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Durcan R; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Hamilton CA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Barker S; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Lloyd J; Nuclear Medicine Department, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Firbank M; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Allan LM; College of Medicine and Health, Exeter University, Exeter, UK.
  • O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Taylor JP; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Thomas AJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Psychol Med ; 52(6): 1147-1155, 2022 04.
Article in En | MEDLINE | ID: mdl-32840196
ABSTRACT

BACKGROUND:

Recently published diagnostic criteria for mild cognitive impairment with Lewy bodies (MCI-LB) include five neuropsychiatric supportive features (non-visual hallucinations, systematised delusions, apathy, anxiety and depression). We have previously demonstrated that the presence of two or more of these symptoms differentiates MCI-LB from MCI due to Alzheimer's disease (MCI-AD) with a likelihood ratio >4. The aim of this study was to replicate the findings in an independent cohort.

METHODS:

Participants ⩾60 years old with MCI were recruited. Each participant had a detailed clinical, cognitive and imaging assessment including FP-CIT SPECT and cardiac MIBG. The presence of neuropsychiatric supportive symptoms was determined using the Neuropsychiatric Inventory (NPI). Participants were classified as MCI-AD, possible MCI-LB and probable MCI-LB based on current diagnostic criteria. Participants with possible MCI-LB were excluded from further analysis.

RESULTS:

Probable MCI-LB (n = 28) had higher NPI total and distress scores than MCI-AD (n = 30). In total, 59% of MCI-LB had two or more neuropsychiatric supportive symptoms compared with 9% of MCI-AD (likelihood ratio 6.5, p < 0.001). MCI-LB participants also had a significantly greater delayed recall and a lower Trails ATrails B ratio than MCI-AD.

CONCLUSIONS:

MCI-LB is associated with significantly greater neuropsychiatric symptoms than MCI-AD. The presence of two or more neuropsychiatric supportive symptoms as defined by MCI-LB diagnostic criteria is highly specific and moderately sensitive for a diagnosis of MCI-LB. The cognitive profile of MCI-LB differs from MCI-AD, with greater executive and lesser memory impairment, but these differences are not sufficient to differentiate MCI-LB from MCI-AD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lewy Body Disease / Alzheimer Disease / Cognitive Dysfunction Type of study: Diagnostic_studies Limits: Humans / Middle aged Language: En Journal: Psychol Med Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lewy Body Disease / Alzheimer Disease / Cognitive Dysfunction Type of study: Diagnostic_studies Limits: Humans / Middle aged Language: En Journal: Psychol Med Year: 2022 Document type: Article Affiliation country:
...